Astragalus polysaccharide alleviates polycystic ovary syndrome by reducing insulin resistance and oxidative stress and increasing the diversity of gut microbiota

被引:3
|
作者
Li, Ruiyun [1 ]
Hu, Rui [1 ]
Huang, Yi [1 ]
Li, Dan [1 ]
Ma, Xiaoling [2 ]
Yang, Yuan [1 ,2 ]
机构
[1] Lanzhou Univ, Clin Med Coll 1, Lanzhou, Peoples R China
[2] Lanzhou Univ, Hosp 1, Lanzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Polycystic ovary syndrome; Astragalus polysaccharide; Ovarian function; Metabolism; Intestinal flora;
D O I
10.1007/s12020-023-03553-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPolycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder, which is frequently accompanied by insulin resistance, oxidative stress (OS), and dyslipidemia. Astragalus polysaccharide (APS)-as a water-soluble heteropolysaccharide-can lower blood sugar and lipid and exert anti-aging effects and thus has been proven to be beneficial to various types of metabolic diseases. However, specific mechanisms of the action of APS on PCOS are yet to be studied.MethodsHerein, BALB/C female mice aged 3 weeks were randomly divided into three groups (10 mice/group): oil + PBS group, DHEA + PBS group, and DHEA + APS group. Changes in the estrous cycle, ovarian tissue sections, serum levels of the hormone, blood glucose, blood lipid, and OS were studied. The intestinal microbiome was sequenced and Spearman correlation analysis was used to analyze the correlation between serum metabolic indexes and microflora.ResultsThe results revealed that APS treatment ameliorated insulin resistance, OS, and dyslipidemia in PCOS mice. The results of 16S rDNA sequencing indicated that there were significant differences in the composition and diversity of intestinal microorganisms between DHEA and APS treatments. Firmicutes, Lachnospiraceae, Bacilli, Lactobacillaceae, and Lachnospiraceae_NK4A13_group were abundant in the oil + PBS group. Bacteroidota and Muribaculaceae were enriched in the DHEA + PBS group, while Rikenellaceae, Odoribacter, and Marinifilaceae were enriched in the DHEA + APS group. Furthermore, Spearman correlation analysis showed that there were close interactions and correlations between intestinal bacteria and indicators of blood glucose, blood lipids, steroid hormones, and OS in PCOS mice.ConclusionsOverall, the study showed that APS improved PCOS in mice by correcting serum metabolic disorders and increasing microbiome diversity, which may provide insight into understanding the pathogenesis and be a beneficial intervention for PCOS.
引用
收藏
页码:783 / 797
页数:15
相关论文
共 50 条
  • [21] Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome
    González, F
    Rote, NS
    Minium, J
    Kirwan, JP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01): : 336 - 340
  • [22] Induction of Oxidative Stress and Human Leukocyte/Endothelial Cell Interactions in Polycystic Ovary Syndrome Patients with Insulin Resistance
    Victor, Victor M.
    Rocha, Milagros
    Banuls, Celia
    Alvarez, Angeles
    de Pablo, Carmen
    Sanchez-Serrano, Maria
    Gomez, Marcelino
    Hernandez-Mijares, Antonio
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (10): : 3115 - 3122
  • [23] Humanin Alleviates Insulin Resistance in Polycystic Ovary Syndrome: A Human and Rat Model-Based Study
    Wang, Yingying
    Zeng, Zhengyan
    Zhao, Shuhua
    Tang, Li
    Yan, Jin
    Li, Nianyu
    Zou, Liping
    Fan, Xiaorong
    Xu, Chengcheng
    Huang, Jin
    Xia, Wei
    Zhu, Changhong
    Rao, Meng
    ENDOCRINOLOGY, 2021, 162 (08)
  • [24] High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota
    Wang, Xuejiao
    Xu, Ting
    Liu, Rui
    Wu, Guojun
    Gu, Liping
    Zhang, Yahui
    Zhang, Feng
    Fu, Huaqing
    Ling, Yunxia
    Wei, Xiaohui
    Luo, Yunchen
    Shen, Jian
    Zhao, Liping
    Peng, Yongde
    Zhang, Chenhong
    Ding, Xiaoying
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [25] Reducing insulin resistance in obese patients with polycystic ovary syndrome using rimonabant as an alternative to metformin
    Sathyapalan, Thozhukat
    Cho, Li Wei
    Kilpatrick, Eric S.
    Coady, Anne-Marie
    Atkin, Stephen L.
    DIABETES, 2008, 57 : A603 - A603
  • [26] Cordyceps polysaccharide improves polycystic ovary syndrome by inhibiting gut-derived LPS/TLR4 pathway to attenuates insulin resistance
    Zhang, Huiwen
    He, Ziwen
    Chen, Yigong
    Chao, Jingtong
    Cheng, Xiamei
    Mao, Jiayin
    Chen, Yulan
    Li, Bo
    Yu, Jingjing
    Yan, Meiqiu
    Chen, Suhong
    Lv, Guiyuan
    Su, Jie
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 280
  • [27] Super Astragalus polysaccharide in specific gut microbiota metabolism alleviates chronic unpredictable mild stress-induced cognitive deficits mice
    Liu, Qing
    Ding, Peng
    Zhu, Ying
    Wang, Chenxu
    Yin, Lifeng
    Zhu, Jian
    Nie, Shuang
    Wang, Shi
    Zheng, Chengjian
    Shen, Hui
    Mo, Fengfeng
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 283
  • [28] Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances
    Karadeniz, M.
    Erdogan, M.
    Tamsel, S.
    Zengi, A.
    Alper, G. E.
    Caglayan, O.
    Saygili, F.
    Yilmaz, C.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (04) : 231 - 235
  • [29] Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction
    Li, Tianhe
    Zhang, Tingting
    Gao, Huimin
    Liu, Ruixia
    Gu, Muqing
    Yang, Yuxi
    Cui, Tianyu
    Lu, Zhongbing
    Yin, Chenghong
    REDOX BIOLOGY, 2021, 41
  • [30] Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome
    Atakul, Nil
    Selek, Sahabettin
    Koktasoglu, Fatmanur Yilmaz
    Kilic, Berna Sermin
    Gul, Ayse Zehra
    Atamer, Yildiz
    ISTANBUL MEDICAL JOURNAL, 2022, 23 (02): : 90 - 95